Physician profile
David E Hartenbach
NPI 1154302131
$623.88
in general payments reported to CMS, 2019-2025
17 companies · $22.62 in 2025
The $22.62 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $97.14 · 2021: $21.80 · 2024: $32.07 · 2025: $22.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $76.92 | 2019-2020 | |
| Tris Pharma INC | $75.45 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $58.82 | 2019-2020 | |
| Shire North American Group INC | $49.61 | 2019 | |
| Pfizer INC. | $48.69 | 2019-2024 | |
| Rhodes Pharmaceuticals L.P. | $46.57 | 2019 | |
| Kaleo, INC. | $45.30 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $42.13 | 2019 | |
| Adlon Therapeutics L.P. | $41.20 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $23.94 | 2019-2020 | |
| Alk-Abello, INC | $22.62 | 2025 | Neffy |
| Supernus Pharmaceuticals, INC. | $21.80 | 2021 | |
| Sanofi Pasteur INC. | $18.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.76 | 2019 | |
| Modernatx, INC. | $13.86 | 2024 | Moderna Covid-19 Vaccine |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.36 | 2019 | |
| Abbvie INC. | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hartenbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.